Tag | Content |
---|
EnhancerAtlas ID | HS073-06719 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr17:79527500-79529130 |
Target genes | Number: 29 | Name | Ensembl ID |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxd3 | MA0041.1 | chr17:79527706-79527718 | AAACAAACAAAC | - | 6.32 | Foxd3 | MA0041.1 | chr17:79527710-79527722 | AAACAAACAAAC | - | 6.32 | Foxd3 | MA0041.1 | chr17:79527714-79527726 | AAACAAACAAAC | - | 6.32 | HES2 | MA0616.2 | chr17:79528125-79528135 | GGCACGTGCC | + | 6.02 | HES2 | MA0616.2 | chr17:79528125-79528135 | GGCACGTGCC | - | 6.02 | POU2F2 | MA0507.1 | chr17:79527957-79527970 | TTAATTTGCATTT | + | 6.25 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_38716 | chr17:79527330-79529454 | HUVEC | SE_46543 | chr17:79527536-79529380 | Osteoblasts | SE_47143 | chr17:79522479-79553053 | Panc1 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr17 | 79527786 | 79528059 | chr17 | 79527600 | 79529000 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I081558 | chr17 | 79525849 | 79536927 |
|
Enhancer Sequence | GAGGTGGGCA GATCACAAAT TCAAGAGATG GAGACCATCC TGGCTAACAT GGTGAAACCC 60 CGTCTCTACT AAAAATGCAA AAATTACCTG GGGGTGGTGG TGCGCACCTG TAATCCCAGC 120 TACTAGGAAG GCTGAGGAAG GAGAATGGCG TGAACCTGGG AGGCGGAGGT TGCAGTGAAC 180 CGAGGTTGCA GTAAGCCGAG ATCTCAAAAC AAACAAACAA ACAAACAACA ACAACAAAAA 240 ACCTACCTAG GAATGAATCT GCCGGCCCAC AGGGTAATGA ATTGTGTGCT GAACTTTCTA 300 AGACCCTGAG ACACAGTTCT CGCGAGGGTG GCACGGTTTT GCCTCCCACT CGCAAGGTAC 360 GAGAGTCCCA GCTGCTTCAC ATCTTCACTC ACACTTGACA TTGTCGCGTT TTTTTCATTT 420 CAGCCACACT GATGAATGTG TAACGGCTTC TCATGTTTTA ATTTGCATTT CCCTGATGAC 480 TAATGATAGT GACTGTTCCT GCATCTCCTT TTTTTTGTTG TTGCCGAGGC TGGAGTGCAA 540 TGGCGCAATC TCGGCTCGCT GCAACCTCTG CCTCCTGGGT TCAAGCGATT CTCCTACCTC 600 AGCCTCCCAA GTAGCTAGGA TTACAGGCAC GTGCCACCAC ACCTGGCTAA TTTTTTTTAT 660 TTTTAGTAGA GATGGGTTTT CACCATGTTG GCCTGGCTGT CTCGAACTCC TGACCTCAAA 720 TGATCCACCG CCTCGGCCTC CCAAAGTGCT GGGATTACAG GCGTGAGCTA CCATGCCCGA 780 CCTGCATTTC CTTTTGTGAA ACGTTTCACC CTCCGCCCAG CTTCTTCTTC TGCTTTCTGT 840 TTGATTAACA ACAGGCAGAG TTATTTTTAA GTTTCAGATA GAAGTCATGT TGTGTGTATG 900 TACTGCTAAT ACTGCGTCCC CCATTGGTGC CTTTTCATGT TTCTAACAGT GCCCTGTGAT 960 GAGCACAAGT GTTTTGTTTA GATAAATTTA TTTATCAATT TACCTATTTT TATGCCAGTG 1020 TTTTTCTGTG TTCTACCCCA AGGTCCTGCA TCCTGCCTAA AAGAATCTTT GCGTACCCCA 1080 AGGCCCTGAA GAGATTCAAC TTAATAACTG TTTTACAGTT TTTATTTTTT TAAGACAGGG 1140 TATTGCTCTG TCATTCAGGC TGGAGTGGTA TAATCATGGC TCACTGTGAC CTCGACCTCC 1200 TGACTCATGG GATCCTCCCA TTTCAGCCTC CCCAGAAGCT GGGATTATAG GCGTGGACCA 1260 CTCACCATGC CCAGCTAATT CTTTTTTTTT TAATATTGTT TTTTTGTACA GACGGGGCTT 1320 CACTATGCTG TGTGGGCTGG TCTCACACTT CTGGGCTACA GTGTCCTCCA GCTTTGGCCT 1380 CCTAGAGTGT TAGGATTATA GCTATGAGAC ATCATGCCCA GCCTGCTTCA TAGTTTTACC 1440 TTTTACCATT AGGCCTATGA CCCATCCTGA GCTGATCTTT GTGTCTTGTG TATACACGTC 1500 TGTAATCCCA GCACTTTGGG AGACCGAGGC AGGTGGATCA CCTGAGGTCA GGAGTTCCAG 1560 ACCAGCCTGA CCAACATGGT GAAACCCCAT CTCTACTAAA AATATAAAAA TTAGCCAGGC 1620 GTGGGTGCAC 1630
|